45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Mark E. Robson, MD

Clinical Director, Clinical Genetics Service
Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, NY
USA 10065

Papers:
193 - Poster Session A Breast cancer risk with hormone replacement after risk-reducing Salpingo-oophorectomy in BRCA mutation carriers: does it abrogate the benefit?